Javascript är inaktiverat

Inbjudna föreläsare

Marc Bonaca

Marc Bonaca, MD, MPH, is a cardiologist and vascular medicine specialist serving as executive director of CPC and Director of Vascular Research & Professor of Medicine at the University of Colorado Anschutz.

Dr. Bonaca earned his medical degree from the University of Connecticut and his MPH at Harvard. He completed his medical residency, cardiology fellowship, and vascular medicine fellowship at Brigham and Women’s Hospital and a dedicated research fellowship at the TIMI Study Group.
He became faculty at BWH and Harvard Medical School and an investigator at TIMI. He directed pharmacovigilance at TIMI and was an investigator on several large outcomes trials including TRA2P-TIMI 50, PEGASUS-TIMI 54, DECLARE-TIMI 58, and REAL TIMI 63B.

In 2018, he joined the faculty at the University of Colorado as Professor of Medicine and the William R. Hiatt Endowed Chair in Cardiovascular Research. He is the Executive Director of CPC, an affiliated non-profit Academic Research Organization. At CPC, he has led several clinical trials with CPC as the lead ARO, including VOYAGER PAD, PREVENT HD, ASPEN, and BRIGHT, and is leading several ongoing trials, including EVOLVE MI and MOONRAKER program that includes REDEFINE-HF, CONFIRMATION-HF and FINALITY-HF studies.

Dr. Bonaca’s research focus is on ischemic risk with atherosclerotic vascular disease, risk prediction, and risk modification using pharmacologic and biologic therapies. He has extensive experience designing and conducting large, multicenter randomized clinical trials, and analyzing registries and real-world datasets. His areas of interest include PAD, PVD, and diabetes, with a focus on the breadth of risk including ischemic limb outcomes, microvascular complications, and major adverse cardiovascular events. He is also investigating the cardiac, vascular, and thrombotic complications associated with novel oncologic therapies. At CPC, he has focused on building a robust faculty and operational group dedicated to high quality, efficient trials leveraging health networks, informatics, and decentralized design.

Koen Deloose

Koen Deloose, MD, is head of the Department of Vascular Surgery in AZ Sint Blasius
Dendermonde. As an active researcher, Dr Deloose has authored and co-authored
more than 200 articles in peer-reviewed medical journals, more than 10 chapters in
orthopedic, vascular and endovascular books and many posters and papers in
conference proceedings. He is member of the editorial Board, Endovascular Section,
of the Journal of Cardiovascular Surgery, the Journal of Vascular and Endovascular
Therapy and the Journal of critical limb ischemia. He is founding director of the clinical
research organization (CRO) ID3 Medical, (co-)running 16 different trials. Dr Deloose
is founding co-Course director and board member of the organizing Committee of Paris
Vascular Insigths (Paris, France) congress and member of the EVC Maastricht board,
arterial section.

Marta Lobato

Dr Lobato has been a Vascular and endovascular Surgery Consultant in Hospital 
Universitario de Cruces (Bilbao-Spain) since 2010. Her Department is considered 
a first line Unit in the Endovascular management of CLTI ( particularly in the BTK-BTA segments). 
She developed her Vascular Fellowship Programme in Hospital Universitario Doce de Octubre 
(Madrid) and thereafter completed her training with short stages in Hospital du Nord St Etienne (France),
Universitäs Spital Zurich. (Switzerland), St Franziskus Hospital Münster.(Germany)
For the last ten years her activity has been mainly focused in the endovascular treatment of 
the lower limb,routinely performing complex CTO revascularizations, including any sort of bidirectional access,
transcollateral approaches, plantar loop or venous arterialization. She is also a reviewer of the 
Critical Limb ischaemia Journal, Journal of Endovascular Therapy and Annals of Vascular Surgery since 2024. 
Her Unit has presented multiple communications in well recognized international symposiums and has 
published many papers in first line journals of her speciality.

Konstantinos Stavroulakis

Associate Professor of vascular Surgery Ludwig, Maximilian University of Munich, 
Head of vascular and endovascular Surgery unit, Mathias Spital Rheine, Germany.